影像学与活检在前列腺癌诊断中的应用:亚洲前列腺影像工作组的一项调查
亚洲前列腺影像工作组向韩国、日本、新加坡和中国台湾的专业学会成员发放问卷,调查前列腺癌诊断中影像学与活检的使用情况,应答率97.3%(108/111)。结果显示各国在MRI设备场强、b值、报告系统、PET示踪剂及活检方式等方面存在较大差异,作者据此提示需要开展教育项目以推广标准化的循证影像方法。
要点
- 前列腺MRI最常用于疑似前列腺癌的活检初治患者(日本、新加坡)或已确诊前列腺癌的分期(韩国、台湾)。
- 前列腺靶向活检在63.8%的医院开展,通常采用MRI-超声融合方式。
- 各国前列腺MRI技术参数与报告系统使用率差异较大,提示需推动标准化。
核心结论
- 调查显示亚洲四地在评估前列腺癌时,影像学技术细节和活检可及性存在多样性。
- 作者认为这一结果提示需要为亚洲放射科医生制定教育项目,以推广前列腺癌诊断与分期的标准化循证影像方法。
研究设计与样本
- 亚洲前列腺影像工作组设计了一份涵盖前列腺MRI、其他前列腺影像、前列腺活检和前列腺癌背景四个领域的调查问卷。
- 问卷发送至韩国、日本、新加坡和中国台湾的专业学会成员共111人,这些成员为其所在工作医院的代表,应答率为97.3%(108/111),并对回复进行分析。
关键影像表现/征象
- 前列腺MRI使用3T扫描仪的比例范围为21.6%-78.9%,使用解痉剂的比例范围为22.2%-84.2%,使用泻药的比例范围为2.3%-26.3%,使用前列腺影像报告和数据系统报告的比例范围为59.5%-100%。
- 受访者报告使用的最高b值范围为800-2000 sec/mm²,视野范围为9-30 cm。
- 每月前列腺MRI检查量范围为1至600例。
- 前列腺MRI最常见的检查时机是活检前(29.9%)。
- 前列腺靶向活检在63.8%的医院开展,通常采用MRI-超声融合方式。
临床应用与阅片要点
- 在活检初治的疑似前列腺癌患者中,日本和新加坡最常使用前列腺MRI;在已确诊前列腺癌的分期患者中,韩国和中国台湾最常使用前列腺MRI。
- 前列腺正电子发射断层显像最常用的示踪剂在新加坡为前列腺特异性膜抗原,在其他三个国家/地区为氟脱氧葡萄糖。
- 四地最常见的临床表现均为局限性前列腺癌,通常采用根治性前列腺切除术治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To elucidate the use of radiological studies, including nuclear medicine, and biopsy for the diagnosis and staging of prostate cancer (PCA) in clinical practice and understand the current status of PCA in Asian countries via an international survey.
MATERIALS AND METHODS: The Asian Prostate Imaging Working Group designed a survey questionnaire with four domains focused on prostate magnetic resonance imaging (MRI), other prostate imaging, prostate biopsy, and PCA backgrounds. The questionnaire was sent to 111 members of professional affiliations in Korea, Japan, Singapore, and Taiwan who were representatives of their working hospitals, and their responses were analyzed.
RESULTS: This survey had a response rate of 97.3% (108/111). The rates of using 3T scanners, antispasmodic agents, laxative drugs, and prostate imaging-reporting and data system reporting for prostate MRI were 21.6%-78.9%, 22.2%-84.2%, 2.3%-26.3%, and 59.5%-100%, respectively. Respondents reported using the highest b-values of 800-2000 sec/mm² and fields of view of 9-30 cm. The prostate MRI examinations per month ranged from 1 to 600, and they were most commonly indicated for biopsy-naïve patients suspected of PCA in Japan and Singapore and staging of proven PCA in Korea and Taiwan. The most commonly used radiotracers for prostate positron emission tomography are prostate-specific membrane antigen in Singapore and fluorodeoxyglucose in three other countries. The most common timing for prostate MRI was before biopsy (29.9%). Prostate-targeted biopsies were performed in 63.8% of hospitals, usually by MRI-ultrasound fusion approach. The most common presentation was localized PCA in all four countries, and it was usually treated with radical prostatectomy.
CONCLUSION: This survey showed the diverse technical details and the availability of imaging and biopsy in the evaluation of PCA. This suggests the need for an educational program for Asian radiologists to promote standardized evidence-based imaging approaches for the diagnosis and staging of PCA.
引用
- Wang LJ, Jinzaki M, Tan CH, et al. Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group. Korean J Radiol. 2023. PMID: 37899520. doi:10.3348/kjr.2023.0644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。